Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/88828
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: XMRV and prostate cancer - a 'final' perspective
Author: Sfanos, K.S.
Aloia, A.L.
De Marzo, A.M.
Rein, A.
Citation: Nature Reviews Urology, 2012; 9(2):111-118
Publisher: Nature Publishing Group
Issue Date: 2012
ISSN: 1759-4812
1759-4820
Statement of
Responsibility: 
Karen S. Sfanos, Amanda L. Aloia, Angelo M. De Marzo & Alan Rein
Abstract: XMRV was first described in 2006, when it was identified in samples isolated from prostate cancer tissues. However, studies have since shown that XMRV arose in the laboratory and was formed by genetic recombination between two viral genomes carried in the germline DNA of mice used during serial transplantation of the CWR22 prostate cancer xenograft. These new findings strongly imply that XMRV does not circulate in humans, but is only present in the laboratory. Thus, there is no reason to believe that it has any role in the etiology of prostate cancer or other diseases.
Keywords: Animals
Humans
Prostatic Neoplasms
DNA, Viral
Male
Xenotropic murine leukemia virus-related virus
Rights: © 2012 Macmillan Publishers Limited. All rights reserved.
DOI: 10.1038/nrurol.2011.225
Published version: http://dx.doi.org/10.1038/nrurol.2011.225
Appears in Collections:Aurora harvest 7
Molecular and Biomedical Science publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.